Literature DB >> 19996253

APOE-epsilon3 and APOE-219G haplotypes increase the risk for schizophrenia in sibling pairs.

Carlos Tovilla-Zarate1, Beatriz Camarena Medellin, Ana Fresan, Rogelio Apiquian, Albana Dassori, Medina Rolando, Michael Escamilla, Humberto Nicolini.   

Abstract

To investigate the role of the apolipoprotein E (APOE) gene in schizophrenia, the authors analyzed 60 families with this mental disorder. An association in the presence of linkage test (APL) and haplotypes analysis were undertaken using the APL v1.1 software. A global allelic transmitted was significant for APOE-epsilon3 (chi(2)=6.24, p=0.01); this allele is mainly carried by female patients (chi(2)=8.33, p=0.003), whereas APOE-219G is preferentially transmitted in males (p=0.02). Furthermore, our results show that haplotypes APOE-epsilon3/APOE-219G are associated with schizophrenia (chi(2)=11.61, p=0.01). These results provide evidence that the APOE gene may play a significant role in the etiology of schizophrenia in the Mexican population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19996253     DOI: 10.1176/jnp.2009.21.4.440

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  3 in total

1.  Association between clinical symptoms and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia.

Authors:  Wenwang Rao; Xiangfei Meng; Keqing Li; Yunshu Zhang; Xiang Yang Zhang
Journal:  Ann Gen Psychiatry       Date:  2021-12-20       Impact factor: 3.455

2.  Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis.

Authors:  Saeed Mohammad Al-Asmary; Saeed Kadasah; Misbahul Arfin; Mohammad Tariq; Abdulrahman Al-Asmari
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

3.  Association between cognitive impairment and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia.

Authors:  Wenwang Rao; Yunshu Zhang; Keqing Li; Xiang Yang Zhang
Journal:  Aging (Albany NY)       Date:  2021-06-16       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.